Drugs Against Calcitonin Gene-Related Peptide and its Receptor Used in the Treatment of Migraine: What are the New Progresses?

Journal Title: Neuro – Open Journal - Year 2015, Vol 2, Issue 3

Abstract

Migraine is a chronic headache disorder that its exact pathomechanism is not very well known but research in the last two decades indicates that it might be a brain disorder, a dismodulation of sensory processing of the brainstem responsible for regulation of vascular tone and the pain. Several neurotransmitters and neuromodulators including neuropeptides have been implicated in the pathomechanism of migraine, among them, Calcitonin gene-related peptide (CGRP) has been the focus of many studies in recent years. Increased CGRP level (perhaps due to release from peripheral and central sensory nerve endings) has been detected in the blood of migraine patients and many basic and clinical investigators in recent years have been trying to block the CGRP receptor by means of newly developed CGRP-receptor antagonist drugs or inhibit its activity by even newer compounds, the monoclonal Antibodies (mAbs) against CGRP or its receptor. These latter ones are still in clinical trials but have had promising results so far in alleviating the pain of migraine patients. This article will briefly review and discuss the role of CGRP and its receptor in migraine and some of the other biological activities of CGRP, the CGRP receptor antagonist drugs and the new progresses in mAbs against CGRP or its receptor.

Authors and Affiliations

Mohtashem Samsam

Keywords

Related Articles

Toxin-Induced Parkinson’s Disease Models

The Topic “Toxin-Induced Parkinson’s Disease Models’ includes articles on experimental neurotoxic chemicals models of Parkinson’s Disease (PD). The model toxicants with differing chemical structures recapitulate PD ownin...

Multiplicity as a Factor in Understanding NF1

The NF1 locus on the long arm of chromosome 17 is a very special gene in the human genome. In terms of multiplicity, there are five pseudogenes on five other chromosomes; it influences the formation and/or behavior of ma...

Treatment of the Carpal Tunnel Syndrome with Laser

Objecive: To test the effectiveness of low intensity laser therapy in patients with carpal tunnel syndrome (CTS). Methods: Patients with clinical and ENMG diagnosis of CTS never previously treated were included and submi...

Vasospasm Monitored by Transcranial Doppler

Vasospasm almost always occurs following rupture of an aneurysm in the Circle of Willis. Spasm is less likely in peripherally located aneurysms, for example those complicating bacterial endocarditis. For a day or two spa...

Neuromodulation in the Treatment of Migraine: Progress in Nerve Stimulation

Migraine is a type of primary headache disorder that can become chronic and disabling. The exact pathomechanism of migraine is not known very well and its treatment is also difficult in some cases. There are several medi...

Download PDF file
  • EP ID EP552577
  • DOI 10.17140/NOJ-2-117
  • Views 90
  • Downloads 0

How To Cite

Mohtashem Samsam (2015). Drugs Against Calcitonin Gene-Related Peptide and its Receptor Used in the Treatment of Migraine: What are the New Progresses?. Neuro – Open Journal, 2(3), 79-91. https://europub.co.uk/articles/-A-552577